Keyword: Stanford University
Insitro has snagged a new chief data officer: Serafim Batzoglou, Ph.D., who previously led Illumina’s applied and computational biology team.
A new study shows how circular ecDNA outside of the chromosome in cancer cells drives oncogenes, making tumors more aggressive.
Backed by results from a small clinical study, Stanford researchers are planning a large trial of AnaptysBio’s anti-IL-33 etokimab in peanut allergy.
Bolt Biotherapeutics presented positive results from animal trials of its lead drug, a tumor-targeting antibody connected to an immune stimulator.
Stanford scientists have identified a molecular defect in Parkinson’s disease and pinpointed a promising drug candidate to target it.
A Stanford team has proposed a strategy for coaxing supporting cells in the brain to transform into memory-preserving neurons.
Stanford researchers discovered that immune cells known for their ability to root out cancer can also kill wayward cells that cause MS.
The week’s biotech news included a map of the human lung that could aid asthma drug development and a compound that thwarts rhinoviruses like colds.
The series A round sets Confo up to advance drugs derived from a novel way of stabilizing GPCRs and performing more sensitive screens.
Inhibiting CD22 may help treat or prevent neurodegenerative diseases by restoring the brain's microglia, a Stanford team found.